WYSS INSTITUTE FOR BIOLOGICALLY INSPIRED ENGINEERING AT HARVARD Alkem Laboratories Limited (Alkem), an Indian multinational pharmaceutical company, has signed a license agreement with Harvard University’s Office of Technology Development (OTD) enabling Alkem to develop and commercialize a novel technology that may help meet the dire need for effective treatment of diabetic neuropathy, foot ulcers, peripheral arterial disease...
Month: <span>February 2022</span>
Post
Facial analysis improves diagnosis
UNIVERSITY OF BONN IMAGE: THE IMAGE SHOWS MATCHES, AN ALLUSION TO MATCHING FACIAL FEATURES AND DISEASES. A GENE SEQUENCE IS ALSO BURNED ONTO THE MATCHES. THIS ENCRYPTION CONTAINS THE TITLE AND THE AUTHORS OF THE STUDY. THE BLUE MATCH HEADS SYMBOLIZE RARE DISEASES. CREDIT: JEAN TORI PANTEL Many sufferers of rare diseases endure an odyssey...
Post
Potential to identify risk of Alzheimer’s in middle age
UNIVERSITY OF OTAGO A simple eye test may make diagnosing the earliest stages of ‘diseases of old age’ possible when people are much younger, University of Otago researchers hope. Parts of our retina have previously been proposed as biomarkers for Alzheimer’s, but researchers from Otago’s Dunedin Multidisciplinary Health and Development Research Unit have been investigating...
Post
Illuminating real-time brain dynamics of neuropeptides with a fluorescent biosensor
UNIVERSITY OF ZURICH IMAGE: CONFOCAL IMAGE OF CULTURED NEURONS EXPRESSING OXLIGHT1 (LEFT) AND STRUCTURAL MODEL OF OXLIGHT1 (RIGHT) CREDIT: UZH In the brain, billions of neural cells act in concert to coordinate both basic and higher functions of the organism. They use a special language to communicate with each other: molecules known as neuropeptides or...
Post
Simplifying RNA editing for treating genetic diseases
UNIVERSITY OF CALIFORNIA – SAN DIEGO New research led by bioengineers at the University of California San Diego could make it much simpler to repair disease-causing mutations in RNA without compromising precision or efficiency. The new RNA editing technology holds promise as a gene therapy for treating genetic diseases. In a proof of concept, UC...
Post
Futuristic coating for hospital fabrics and activewear kills COVID and E. coli
UNIVERSITY OF BRITISH COLUMBIA UBC researchers have developed an inexpensive, non-toxic coating for almost any fabric that decreases the infectivity of the virus that causes COVID-19 by up to 90 percent. And in the future, you might be able to spray it on fabric yourself. “When you’re walking into a hospital, you want to know...
Post
Infusion of 3D cellular structures might repair damaged intestine
TOKYO MEDICAL AND DENTAL UNIVERSITY CREDIT: ASSOCIATE PROFESSOR SHIRO YUI, TMDU Researchers from Tokyo Medical and Dental University (TMDU) develop a protocol to transplant 3D cellular structures that could regenerate damaged intestine Tokyo, Japan – Ulcerative colitis is an inflammatory bowel disease (IBD) that causes inflammation and ulcers (sores) in the digestive tract. Ulcerative colitis...
Post
Researchers identify brain region associated with feeling full after eating
by Mikayla MacE Kelley, University of Arizona Credit: Unsplash/CC0 Public Domain Feeling full, or satiated, after a meal is healthy and normal, but what causes that feeling is complicated and not well understood. New University of Arizona-led research published in the journal Molecular Metabolism has identified a brain region and neural circuitry that mediate satiation, which could...
Post
Newly identified protein may help diagnose ulcerative colitis
by Tohoku University Serum samples of patients with inflammatory bowel disease stored at Tohoku University Hospital. Credit: Yoichi Kakuta et al An international research collaboration has discovered a potential new diagnostic marker for ulcerative colitis in a trans-ethnic analysis of Japanese and white patients. The finding could lead to the development of non-invasive, diagnostic blood...
Post
Arrhythmia genes more common than previously thought
by Will Doss, Northwestern University Credit: Pixabay/CC0 Public Domain By sequencing known genes associated with cardiac arrhythmia risk in more than 20,000 people without an indication for genetic testing, scientists were able to identify pathogenic and likely pathogenic variants in nearly one percent of individuals, according to a study published in Circulation. This rate is higher...